Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Nov;18(11):1475-1486.
doi: 10.1093/neuonc/now107. Epub 2016 May 18.

Reporting of patient-reported health-related quality of life in adults with diffuse low-grade glioma: a systematic review

Daniel M Fountain  1 , Dominic Allen  1 , Alexis J Joannides  1 , Dipankar Nandi  1 , Thomas Santarius  1 , Aswin Chari  1
Affiliations

Reporting of patient-reported health-related quality of life in adults with diffuse low-grade glioma: a systematic review

Daniel M Fountain et al. Neuro Oncol. 2016 Nov.

Abstract

Background: Patient-reported health-related quality of life (HRQoL) analysis can provide important information for managing the balance between treatment benefits and treatment-related adverse effects on quality of life (QoL). This systematic review sought to identify the range of HRQoL measures used for patients with diffuse hemispheric WHO grade II glioma (DLGG) and assess the quality of HRQoL reporting.

Methods: This systematic review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Databases were searched for full-text English articles reporting HRQoL outcomes in adult patients with DLGG.

Results: Eleven different QoL measures were used across the 26 included studies, none of which has been validated in patients with DLGG. Heterogeneity of study design prevented pooled analysis of data investigating the effect of interventions or establishing long-term HRQoL. Low rates of participation at baseline (mean: 64.0%) and high rates of subsequent dropout (2.1% per month) were identified. Five studies gave statistical methods to deal with missing data or provided evidence of clinical significance of HRQoL results.

Conclusions: The results demonstrate a paucity and heterogeneity of reporting of HRQoL in the DLGG literature, highlighting the need for a standardized assessment schedule and set of validated quality-of-life measures for future studies.

Keywords: diffuse low-grade glioma; glioma; health-related quality of life; quality of life.

PubMed Disclaimer

References

    1. Bauchet L. Epidemiology of Diffuse Low-Grade Gliomas. In: Duffau H, ed. Diffuse Low-Grade Gliomas in Adults. London: Springer; 2013:9–30. http://link.springer.com/chapter/10.1007/978-1-4471-2213-5_2 Accessed August 31, 2015.
    1. Zouaoui S, Rigau V, Mathieu-Daudé H et al. . French brain tumor database: general results on 40,000 cases, main current applications and future prospects. Neurochirurgie. 2012;58(1):4–13. - PubMed
    1. Quinn TO, Haley G, Jordonna F et al. . CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008–2012. Neuro Oncol. 2015;17(suppl 4): iv1–iv62. - PMC - PubMed
    1. CBTRUS. CBTRUS 2009–2010 Eighteen States Statistical Report Tables Hinsdale: Central Brain Tumor Registry of the United States; 2009.
    1. Taphoorn MJB. Quality of Life in Low-Grade Gliomas. In: Duffau H, ed. Diffuse Low-Grade Gliomas in Adults. London: Springer; 2013:205–217. http://link.springer.com/chapter/10.1007/978-1-4471-2213-5_14 Accessed July 17, 2015.

Publication types